Pathway Capital Management, LP Verona Pharma PLC Transaction History
Pathway Capital Management, LP
- $8.69 Million
- Q1 2025
A detailed history of Pathway Capital Management, LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Pathway Capital Management, LP holds 98,329 shares of VRNA stock, worth $7.1 Million. This represents 71.82% of its overall portfolio holdings.
Number of Shares
98,329Holding current value
$7.1 Million% of portfolio
71.82%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
238Shares Held
68.8MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$462 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$403 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$244 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$226 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$226 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.4B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...